![Anna Sjögren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anna Sjögren
Nessuna posizione attualmente
Profilo
Anna Sjögren worked as Director-Clinical Operations at OxThera AB from 2013 to 2017.
Also worked at Egetis Therapeutics AB as Director-Project & Clinical Development.
Educated at Karolinska Institutet with an undergraduate degree and at the University of Uppsala with an undergraduate degree.
Precedenti posizioni note di Anna Sjögren
| Società | Posizione | Fine |
|---|---|---|
OxThera AB
 OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Corporate Officer/Principal | 01/12/2017 |
| EGETIS THERAPEUTICS AB | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Anna Sjögren
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
